These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36601880)

  • 161. Microsatellite Instability as a Predictor of Outcomes in Colorectal Cancer in the Era of Immune-Checkpoint Inhibitors.
    Lengyel CG
    Curr Drug Targets; 2021; 22(9):968-976. PubMed ID: 33970843
    [TBL] [Abstract][Full Text] [Related]  

  • 162. Predictive biomarkers for response to immune checkpoint inhibitors in lung cancer: PD-L1 and beyond.
    Uruga H; Mino-Kenudson M
    Virchows Arch; 2021 Jan; 478(1):31-44. PubMed ID: 33486574
    [TBL] [Abstract][Full Text] [Related]  

  • 163. Biochemical predictors of response to immune checkpoint inhibitors in unresectable hepatocellular carcinoma.
    Rizzo A; Brandi G
    Cancer Treat Res Commun; 2021; 27():100328. PubMed ID: 33549983
    [TBL] [Abstract][Full Text] [Related]  

  • 164. Immune Checkpoint Inhibition in Colorectal Cancer: Microsatellite Instability and Beyond.
    Cohen R; Rousseau B; Vidal J; Colle R; Diaz LA; André T
    Target Oncol; 2020 Feb; 15(1):11-24. PubMed ID: 31786718
    [TBL] [Abstract][Full Text] [Related]  

  • 165. Tumor mutational burden in colorectal cancer: Implications for treatment.
    Marques A; Cavaco P; Torre C; Sepodes B; Rocha J
    Crit Rev Oncol Hematol; 2024 May; 197():104342. PubMed ID: 38614266
    [TBL] [Abstract][Full Text] [Related]  

  • 166. Immune checkpoint inhibitors in colorectal cancer: limitation and challenges.
    Yan S; Wang W; Feng Z; Xue J; Liang W; Wu X; Tan Z; Zhang X; Zhang S; Li X; Zhang C
    Front Immunol; 2024; 15():1403533. PubMed ID: 38919624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 9.